Chinese biopharma Hansoh Pharmaceutical Group Co and Korean RNAi therapeutics company OliX Pharmaceuticals have announced a licensing and collaboration agreemen 13 October 2021
At a meeting this month, an Institute for Clinical and Economic Review (ICER) committee will assess the comparative clinical effectiveness and value of Bristol 7 October 2021
The value of US gene therapy company Voyager Therapeutics doubled in Wednesday’s early trading following news of a deal with the world’s largest pharma company. 6 October 2021
Rumors that US pharma giant Merck & Co was interested in acquiring Acceleron Pharma (Nasdaq: XLRN) proved to be well-founded after an $11.5 billion deal was con 30 September 2021
British drugmaker AstraZeneca (LSE: AZN) has won approval in Japan for Forxiga (dapagliflozin), a SGLT2 blocker, for chronic kidney disease (CKD). 26 August 2021
Boston, USA-based pricing watchdog The Institute for Clinical and Economic Review (ICER) has published an update to its cost-effectiveness model for therapies i 25 August 2021
Partners Boehringer Ingelheim and Eli Lilly have announced that Jardiance (empagliflozin) 10 mg has been approved by the US Food and Drug Administration (FDA) t 19 August 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.